Increased plasma IL-6 levels are normally associated with obesity and fatty liver disease [1–4], but the involvement of IL-6 in the molecular mechanisms underlying the pathogenesis of lipid and carbohydrate metabolism is not fully understood [5–7]. This evidence concerns the gene IL6 and obesity disorder.